Published in Support Care Cancer on October 02, 2015
Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans. Support Care Cancer (2016) 0.77
Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives. Cancer Manag Res (2016) 0.75
Hyponatremia. N Engl J Med (2000) 11.31
Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med (2007) 6.97
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med (2013) 4.34
Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med (2009) 3.76
Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med (2010) 2.67
The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) (2006) 2.16
Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis (2011) 1.96
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med (1995) 1.66
Characteristics and mortality of severe hyponatraemia--a hospital-based study. Clin Endocrinol (Oxf) (2006) 1.66
Medical costs of abnormal serum sodium levels. J Am Soc Nephrol (2008) 1.56
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol (2011) 1.54
Diagnosis and management of hyponatremia in cancer patients. Oncologist (2012) 1.47
The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol (2010) 1.25
The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer (2009) 1.21
Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients. Postgrad Med J (2009) 1.18
Cost of illness of hyponatremia in the United States. Cost Eff Resour Alloc (2006) 1.16
Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int (2013) 1.12
Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad Med (2009) 1.10
Diagnosis and management of hyponatremia in acute illness. Curr Opin Crit Care (2008) 1.10
Hyponatraemia-SIADH in lung cancer diagnostic and treatment algorithms. Crit Rev Oncol Hematol (2015) 0.88
SEOM guidelines on hydroelectrolytic disorders. Clin Transl Oncol (2014) 0.85
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma. Support Care Cancer (2014) 0.85
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Support Care Cancer (2015) 0.85
The Incidence of Hyponatraemia and Its Effect on the ECOG Performance Status among Lung Cancer Patients. J Clin Diagn Res (2013) 0.85
Determinants of patient satisfaction with care in a Spanish oncology day hospital and its relationship with quality of life. Psychooncology (2013) 0.82